Delicate role of PD-L1/PD-1 axis in blood vessel inflammatory diseases: current insight and future significance

P Veluswamy, M Wacker, M Scherner… - International Journal of …, 2020 - mdpi.com
Immune checkpoint molecules are the antigen-independent generator of secondary signals
that aid in maintaining the homeostasis of the immune system. The programmed death …

PD-1/PD-L1 in cardiovascular disease

YF Sun, L Li, YW Wu, KP Yang - Clinica Chimica Acta, 2020 - Elsevier
Abstract The PD-1/PD-L1 coinhibitory pathway has critical roles in the immune response
and autoimmunity via the regulation of T cell activity. Excessive activity and high expression …

The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease

CM Weyand, GJ Berry, JJ Goronzy - Journal of leukocyte …, 2018 - academic.oup.com
Because of their vital function, the wall structures of medium and large arteries are
immunoprivileged and protected from inflammatory attack. That vascular immunoprivilege is …

PD-1/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications

MA Ortega, DL Boaru, D De Leon-Oliva… - Journal of Molecular …, 2024 - Springer
Abstract The PD-1/PD-L1 axis is a complex signaling pathway that has an important role in
the immune system cells. Programmed cell death protein 1 (PD-1) acts as an immune …

[HTML][HTML] The therapeutic potential of PD-1/PD-L1 pathway on immune-related diseases: based on the innate and adaptive immune components

P Zhang, Y Wang, Q Miao, Y Chen - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Currently, immunotherapy targeting programmed cell death 1 (PD-1) or programmed death
ligand 1 (PD-L1) has revolutionized the treatment strategy of human cancer patients …

Mechanisms of PD-L1 regulation in malignant and virus-infected cells

H Farrukh, N El-Sayes, K Mossman - International Journal of Molecular …, 2021 - mdpi.com
Programmed cell death protein 1 (PD-1), a receptor on T cells, and its ligand, PD-L1, have
been a topic of much interest in cancer research. Both tumour and virus-infected cells can …

Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation

D Bu, M Tarrio, E Maganto-Garcia… - … , and vascular biology, 2011 - Am Heart Assoc
Objective—Programmed cell death-1 (PD-1) is a member of the CD28 superfamily that
delivers negative signals on interaction with its 2 ligands, PD-L1 and PD-L2. We studied the …

Programmed cell death ligand‐1: A dynamic immune checkpoint in cancer therapy

M Kalim, MS Iqbal Khan, J Zhan - Chemical biology & drug …, 2020 - Wiley Online Library
Antibody‐based immunotherapies play a pivotal role in cancer research with efficient
achievements in tumor suppression. Tumor survival is assisted by modulation of immune …

Roles of PD-1/PD-L1 pathway: signaling, cancer, and beyond

L Ai, A Xu, J Xu - Regulation of Cancer Immune Checkpoints: Molecular …, 2020 - Springer
Immunotherapies that target PD-1/PD-L1 axis have shown unprecedented success in a wide
variety of human cancers. PD-1 is one of the key coinhibitory receptors expressed on T cells …

Programmed death-ligand 1 as a regulator of tumor progression and metastasis

IA Vathiotis, G Gomatou, DJ Stravopodis… - International Journal of …, 2021 - mdpi.com
Programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) immune
checkpoint has long been implicated in modeling antitumor immunity; PD-1/PD-L1 axis …